Independent evaluation of Artemisinin monotherapy replacement in the private sector to support the containment of Artemisinin-resistant malaria in Burma

This document describes a summary of evaluations for the Myanmar Artemisinin Monotherapy Replacement Malaria Project (AMTR), which aimed to combat artemisinin-resistant malaria by promoting the use of quality-assured artemisinin combination therapy (QA-ACT) in the private sector. Funded by UKAid from DFID and supported by partners including the Bill and Melinda Gates Foundation, the project employed a mix of qualitative and quantitative methods to assess its effectiveness. The evaluations revealed that the project successfully increased QA-ACT usage and improved fever treatment, but faced sustainability issues, low testing rates, and difficulties in treating confirmed positive cases. Despite challenges such as illegal imports of monotherapies and risks of expired drugs, the project influenced the market for anti-malarials and raised awareness for malaria testing. Recommendations for future interventions include continued private sector engagement and donor support to sustain treatment availability and resistance containment. The evaluations concluded that while the project made significant strides, it must address sustainability and diagnostic testing to ensure long-term success in malaria treatment and resistance management. **This summary was written by an AI model and therefore should not be considered a definitive summary of the report. If you are aware of inaccuracies, please email evaluation.registry@cabinetoffice.gov.uk.**

Description

• Lead department: Closed organisation: Department for International Development
• Evaluation stage: A complete evaluation report
• Other departments: No other departments listed
• Evaluation types: Impact evaluation
• Impact methods: Theory-based methods
• Theory-based methods: Other
• Grant information: This intervention is not distributing funding via a grant
• Government Major Project information: This intervention is not a major project
• Policies: No policies provided

Event Dates

• Event Name: Publication of final results
• Event date: May 2018

Evaluation Costs

• Cost: Not provided

Evaluation sharing

• Link(s) to published report(s): Yes
• Links to evaluation plans: No link provided
• Findings: Not provided
• Permission to share confirmed: Yes